| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Seattle Venture Capital Watch: Modumetal, Illumagear, HaptX & More | Jeff Buchanan | 02/28/19 | Seattle |
| Bluegrass Vascular Opens U.S. Clinical Trial for Obstructed Veins | David Holley | 01/18/18 | Texas |
| Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More | Alex Lash | 08/11/17 | National |
| NxStage Medical Sells to Dialysis Giant Fresenius for $2B | Ben Fidler | 08/07/17 | Boston |
| Bluegrass Vascular Gets Funding, Signs Distribution Deal With Merit | David Holley | 03/06/17 | Texas |
| Texas Roundup: Rackspace, PatientIO, Circular Board, Bluegrass Vascular | Angela Shah | 09/01/16 | Texas |
| Path Cleared for Bluegrass Vascular’s Vein-Access Device in Europe | David Holley | 08/30/16 | Texas |
| East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More | Ben Fidler | 12/05/14 | Boston |
| Proteon Cuts Price, Boosts Shares to Bag $61M in IPO | Ben Fidler | 10/22/14 | Boston |
| Proteon, Moving on From Ill-Fated Novartis Deal, Files IPO Pitch | Ben Fidler | 09/16/14 | Boston |
| With Novartis Deal Dead, Proteon Embarks on Plan B With $45M Round | Ben Fidler | 05/16/14 | Boston |
| Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone | Ben Fidler | 03/18/14 | Boston |
| CytoPherx Raises $34M Toward Finishing Clinical Trial | Sarah Schmid Stevenson | 01/05/12 | Detroit Ann Arbor |
| Stromedix, with Biogen Idec Roots, Seeks Exit from Regulatory Limbo | Ryan McBride | 07/20/10 | Boston |
| AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News | Erin Kutz | 07/09/10 | Boston |
| Amag Pharma Gets $60M Upfront in Licensing Deal with Takeda | Ryan McBride | 04/01/10 | Boston |
| NxStage Medical Rebounds on Wall Street, Looks to Grow Home Dialysis Biz | Ryan McBride | 02/02/10 | Boston |
